Molbio Diagnostics shares rise 9% after Jefferies starts coverage with buy rating: report
The brokerage set a target price of Rs 1,600, implying an upside of about 27 per cent over the stock’s previous close of Rs 1,255.60. New Delhi: Shares of Molbio…
Sun Pharma plans Rs 10,000 crore rupee bond sale to refinance Organon bridge loan: sources
The drugmaker is expected to issue bonds with maturities of two, three and four years to replace part of a bridge loan of nearly $12 billion. Mumbai: Sun Pharmaceutical Industries…
IHH to raise Fortis Healthcare stake to 51% over three to five years: exchange filing
The Malaysian hospital group also said it would fully cooperate with a forensic audit that the Supreme Court allowed to proceed last week. New Delhi: IHH Healthcare plans to lift…
